Portfolio company
Alpheus Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops a non-invasive sonodynamic therapy platform using low-intensity ultrasound and tumor-localising drugs to treat patients with glioblastoma and other brain cancers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alpheus
This clinical-stage company develops a non-invasive sonodynamic therapy platform for the treatment of patients with brain cancer and other solid body tumours.
Cordance Medical
This company develops a focused ultrasound device to open the blood-brain barrier for clinicians treating patients with brain tumours and other neurological diseases.
Carthera
This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.
QV Bioelectronics
The company develops implantable bioelectronic devices that deliver electric field therapy to treat patients with aggressive brain tumours.
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
Exact Therapeutics
The company develops an ultrasound-mediated platform for delivering targeted therapies to patients with cancer, neurological conditions and infectious diseases.
GT Medical Technologies
This company produces bioresorbable radiotherapy implants for patients with operable brain tumors to deliver targeted radiation immediately following surgical removal.
Neurolase
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
